E-LIB Suche - Ergebnisse für: van Engen, A.

1

HTA290 Environmental Sustainability in HTA: Are HTA Bodies ..:

Szawara, P. ; Chu, J. ; Lekhwar, P....
Value in Health. 26 (2023) 12 - p. S376 , 2023

Link: https://doi.org/10.1016/..

2

Corrigendum to 'Salivary gland cancer: ESMO–European Refere..:

van Herpen, C. ; Vander Poorten, V. ; Skalova, A....
ESMO Open. 8 (2023) 5 - p. 101630 , 2023

Link: https://doi.org/10.1016/..

3

HTA73 Health Technology Assessment (HTA) Timelines Analysis..:

Zlateva, J. ; Lalova, T. ; Szawara, P...
Value in Health. 26 (2023) 12 - p. S332-S333 , 2023

Link: https://doi.org/10.1016/..

4

HTA364 Can Artificial Intelligence and Machine Learning Be ..:

Szawara, P. ; Zlateva, J. ; Kotseva, F....
Value in Health. 26 (2023) 12 - p. S390 , 2023

Link: https://doi.org/10.1016/..

5

HTA219 Examining the Awareness and Perceptions of EU HTA Am..:

McCarthy, M. ; Samaha, D. ; van Engen, A.
Value in Health. 26 (2023) 12 - p. S361-S362 , 2023

Link: https://doi.org/10.1016/..

6

PB1033 Delphi Consensus Recommendations for Neuraxial Anest..:

Peterson, W. ; Martin, R. ; Arnold, D....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 100803 , 2023

Link: https://doi.org/10.1016/..

7

HTA97 Impact of Additive PICOs in a European Joint Health T..:

van Engen, A ; Kruger, R ; Ryan, J.
Value in Health. 25 (2022) 12 - p. S315 , 2022

Link: https://doi.org/10.1016/..

8

HTA77 The Use and Acceptability of External Comparator Stud..:

Dijkhuis, S ; Patel, D ; Foster, S..
Value in Health. 25 (2022) 12 - p. S311 , 2022

Link: https://doi.org/10.1016/..

9

HTA38 When and How Does RWE Impact HTA Outcomes in Oncology..:

Oswald, C ; Anastasaki, E ; Dunton, K...
Value in Health. 25 (2022) 12 - p. S303 , 2022

Link: https://doi.org/10.1016/..

10

Salivary gland cancer: ESMO–European Reference Network on R..:

van Herpen, C. ; Vander Poorten, V. ; Skalova, A....
ESMO Open. 7 (2022) 6 - p. 100602 , 2022

Link: https://doi.org/10.1016/..

11

HPR59 The Pharmaceutical Reimbursement and Access Pathways ..:

Kruger, R ; van Engen, A ; Wagner, P..
Value in Health. 25 (2022) 12 - p. S243 , 2022

Link: https://doi.org/10.1016/..

12

HTA9 Differences in Guidance on Pro Evidentiary Requirement..:

Chassany, O ; van Engen, A ; Lai, L...
Value in Health. 25 (2022) 7 - p. S505 , 2022

Link: https://doi.org/10.1016/..

13

HTA88 Similarities and Differences in Scientific Advice Pro..:

Gallinger, P ; Bonduelle, D ; Gaultney, J..
Value in Health. 25 (2022) 12 - p. S313 , 2022

Link: https://doi.org/10.1016/..

14

HTA259 Overlaps and Differences in the PICO Criteria Betwee..:

Gallinger, P ; Bonduelle, D ; Mattern, F...
Value in Health. 25 (2022) 12 - p. S347 , 2022

Link: https://doi.org/10.1016/..

15

POSC273 Has IQWiG's 15% Response Threshold Made a Minimally..:

Kruger, R ; Strydom, M ; Wagner, P.
Value in Health. 25 (2022) 1 - p. S187 , 2022

Link: https://doi.org/10.1016/..